PILL.CN - Canntab Therapeutics Limited

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 513.92M
Enterprise Value 312.33M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)57.99
Price/Book (mrq)6.11
Enterprise Value/Revenue 351.37
Enterprise Value/EBITDA 6-6.17

Trading Information

Stock Price History

Beta (3Y Monthly) -1.95
52-Week Change 3-60.00%
S&P500 52-Week Change 38.78%
52 Week High 31.7700
52 Week Low 30.4000
50-Day Moving Average 30.5436
200-Day Moving Average 30.6460

Share Statistics

Avg Vol (3 month) 320.61k
Avg Vol (10 day) 328.22k
Shares Outstanding 525.31M
Float 17.31M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Aug. 15, 2019) 424.2k
Short Ratio (Aug. 15, 2019) 40.71
Short % of Float (Aug. 15, 2019) 4N/A
Short % of Shares Outstanding (Aug. 15, 2019) 40.10%
Shares Short (prior month Jul. 15, 2019) 41.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar. 8, 2016
Last Split Factor (new per old) 2200/1
Last Split Date 3Apr. 20, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends May 31, 2019
Most Recent Quarter (mrq)May 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-866.08%

Management Effectiveness

Return on Assets (ttm)-35.39%
Return on Equity (ttm)-74.84%

Income Statement

Revenue (ttm)240k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)1,347.80%
Gross Profit (ttm)143.61k
EBITDA -2M
Net Income Avi to Common (ttm)-2.46M
Diluted EPS (ttm)-0.0970
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.59M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.20
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-2.33M
Levered Free Cash Flow (ttm)-1.28M